mRNA |
TL-2-105 |
GDSC1000 |
pan-cancer |
AAC |
0.073 |
0.02 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.02 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.03 |
mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.03 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.03 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.03 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.03 |
mRNA |
BRD-K85133207 |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.03 |
mRNA |
Panobinostat |
CCLE |
pan-cancer |
AAC |
0.088 |
0.03 |